When Oreos Outperformed Statins: The Study That Should Have Changed Medicine
Statins are the world’s #1 prescribed drug, but a shocking experiment showed Oreos lowered LDL nearly twice as much. Here’s what Dr. Nick Norwitz discovered—and why no one’s talking about it.
Lean Mass Hyper-Responders: One-Year Data That Could Shift the Cholesterol Paradigm
The new Lean Mass Hyper-Responder (LMHR) study challenges everything we’ve been told about cholesterol. Despite LDL levels averaging 254 mg/dL, most metabolically healthy participants showed no plaque progression after one year. As someone who has followed a low-carb and animal-based lifestyle for nearly a decade, I know firsthand how unsettling “high cholesterol” numbers can be. Yet this study suggests context—insulin resistance, inflammation, existing plaque—may matter more than LDL alone. Could this finally mark the beginning of a shift in the old cholesterol paradigm?
Cholesterol Is Not a Disease: Why We Should Be Looking at Sugar Instead
Statins are the world’s #1 prescribed drug, but a shocking experiment showed Oreos lowered LDL nearly twice as much. Here’s what Dr. Nick Norwitz discovered—and why no one’s talking about it.